POSB108 Cost-Effectiveness and Cost-Utility Analyses of Atezolizumab-Based Therapy in Patients with Advanced or Unresectable Hepatocellular Carcinoma in Italy
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.381
https://www.valueinhealthjournal.com/article/S1098-3015(21)02176-8/fulltext
Title :
POSB108 Cost-Effectiveness and Cost-Utility Analyses of Atezolizumab-Based Therapy in Patients with Advanced or Unresectable Hepatocellular Carcinoma in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02176-8&doi=10.1016/j.jval.2021.11.381
First page :
Section Title :
Open access? :
No
Section Order :
11162